ALLIANCE FOR CELL THERAPY NOW

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2021–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	4	1
2021	—	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ANDREW VOGT STRATEGIES LLC	—	8

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	7
SENATE	7
Natl Institutes of Health (NIH)	5
Food & Drug Administration (FDA)	3

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	8
Budget/Appropriations	Budget/Appropriations	5

Bills Explicitly Cited (2)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 941117th Congress

TRANSPLANT Act of 2021

2021 · second_quarter · Firm: ANDREW VOGT STRATEGIES LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 941/S. 288, TRANSPLANT Act of 2021; Appropriations for the National Institutes of Health and support for an outcomes database for adult cellular therapies

Client expense: — · Firm income: —

Matched citations: H.R. 941

S. 288117th Congress

TRANSPLANT Act of 2021

2021 · second_quarter · Firm: ANDREW VOGT STRATEGIES LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 941/S. 288, TRANSPLANT Act of 2021; Appropriations for the National Institutes of Health and support for an outcomes database for adult cellular therapies

Client expense: — · Firm income: —

Matched citations: S. 288

Source: Senate LDA

ALLIANCE FOR CELL THERAPY NOW — Lobbying Disclosure | Poliscope